Although hair loss a shocking side effect, Dr. Vijaya Surampudi, assistant director of the

Semaglutide — better known by the brand names Ozempic and Wegovy — and tirzepatide, sold under the brand name Mounjaro, were originally intended for people with Type 2 diabetes. But the medications are frequently prescribed for weight loss, as well. (Wegovy is approved for weight loss by the Food and Drug Administration, while Ozempic and Mounjaro are given off-label. เว็บคาสิโนยอดนิยม